Navigation Links
John Theurer Cancer Center Announces Positive Results from Revlimid MCL-001(EMERGE) Study Leading to FDA Approval of First Oral Therapy for Refractory Mantle-Cell Lymphoma (MCL) Patients
Date:9/26/2013

HACKENSACK, N.J., Sept. 26, 2013 /PRNewswire/ -- Andre Goy, M.D., M.S., Chairman and Director of John Theurer Cancer Center and Chief of the Lymphoma Program, has just published two important papers in relapsed/refractory mantle-cell lymphoma (MCL) in the Journal of Clinical Oncology and New England Journal of Medicine. MCL is a difficult subtype of non-Hodgkin lymphoma, where patients often become chemoresistant after responding to initial therapy.

Dr. Goy, an international expert in the field, led the lenalidomide global pivotal trial known as MCL-001 or EMERGE trial. Lenalidomide belongs to a category of immunomodulators that is first-in-class approved for lymphoma. This Phase II study showed that lenalidomide induced rapid and prolonged response in patients who were heavily pretreated regardless of the number of their prior regimens and with a median duration of response of more than 16 months. Many of these patients had also been refractory to their last prior therapy. The EMERGE trial results were published in the leading Journal of Clinical Oncology ("Single-Agent Lenalidomide in Patients With Mantle-Cell Lymphoma Who Relapsed or Progressed After or Were Refractory to Bortezomib: Phase II MCL-001 (EMERGE) Study" JCO September 2013).

"This trial led to the recent approval by the FDA of lenalidomide as the first oral compound available for that disease addressing a definite unmet need for these patients," said Andre Goy, M.D., M.S., Chairman and Director, and Chief of Lymphoma, John Theurer Cancer Center and Chief Science Officer and Director of Research and Innovation of Regional Cancer Care Associates. "Lenalidomide is only the second drug ever approved for the treatment of mantle-cell lymphoma."

The second study was published in the New England Journal of Medicine a few weeks ago in collaboration
'/>"/>

SOURCE John Theurer Cancer Center
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Revolutionary Natural Sunscreen That Can Reverse Wrinkles, Fine Lines, Sagging Skin, Laugh Lines And Potentially Reverse Cancer Cell Formation With Anti-Aging And Anti-Cancer Forming Natural Ingredients Now Available From Rejuve MD
2. New Survey Reveals U.S. Men with Advanced Prostate Cancer Worry More about Burdening Family and Friends Than Dying
3. Lilly Announces Second Positive Ramucirumab Phase III Gastric Cancer Study Meets Primary Endpoint; Phase III Lilly/TRIO Breast Cancer Study Misses Primary Endpoint
4. Laser-Proton Therapy Working Group Takes Second Look at Ways to Lower Cost of Advanced Cancer Treatment
5. APPLIED INTEGRIN SCIENCES, INC. LAUNCHES CROWDFUNDING CAMPAIGN TO RAISE FUNDS FOR ITS CANCER DRUG DEVELOPMENT PROGRAM
6. In Turkey, the Use of Targeted Therapies Will Continue to Sustain the Colorectal Cancer Drug Market
7. According to Surveyed U.S. Oncologists, Zytiga is the Patient-Share Leader in First-Line Metastatic Castrate-Resistant Prostate Cancer
8. MabVax Therapeutics Receives $1,750,000 Small Business Innovation Research Contract Award From The National Cancer Institute To Support Development of Novel Pancreatic Cancer Diagnostic Imaging Agent
9. K94 Discoveries, Inc. Announces Seed Financing To Advance Targeted Drug Conjugates To Treat Pancreatic And Other Cancers
10. Chrysalis BioTherapeutics, Inc., Receives $1.5m from the National Cancer Institute to Mitigate Radiotherapy-Induced Brain Tissue Damage
11. Study Suggests that a Single Session of Stereotactic Body Radiation Therapy (Lung Radiosurgery) is a Promising Approach for Treating Inoperable Early-Stage Lung Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... TORONTO , May 22 2015 /CNW/ - The Taskforce ... are very appreciative of all the hard work that the ... the past six months. This program recognizes the needs of ... receive at least $75,000 a year, tax free, with annual ... will be eligible for annual payments of $100,000 based on ...
(Date:5/22/2015)... YORK , 22 de mayo de ... DPRX ), una compañía farmacéutica de ... comercialización de Locilex® (pexiganan cream 0.8%), y ... una presentación de póster destacando el diseño ... 3 de la Compañía que evalúan Locilex®, ...
(Date:5/22/2015)... N.C. , May 22, 2015  Effective ... to pharmaceutical brand recognition and success. ... conducted a study to provide pharmaceutical and biotech ... investment (FTEs and budget) that are being channeled ... and biotech marketing managers can utilize this report ...
Breaking Medicine Technology:Dipexium anuncia presentación en el séptimo Simposio Internacional sobre el Pie Diabético 2Dipexium anuncia presentación en el séptimo Simposio Internacional sobre el Pie Diabético 3Dipexium anuncia presentación en el séptimo Simposio Internacional sobre el Pie Diabético 4Dipexium anuncia presentación en el séptimo Simposio Internacional sobre el Pie Diabético 5Dipexium anuncia presentación en el séptimo Simposio Internacional sobre el Pie Diabético 6Effective Marketing Services Group Critical for Pharmaceutical Brand Recognition 2
... and Chicago To Launch,Collaborative Initiative, NEW YORK, ... speed,treatment and cures for pediatric brain tumors and ... the initial phase of a tissue,bank consortium designed ... and cures for these types of cancer, where ...
... Study to Evaluate Preventive Treatment of ... Life Threatening Vulnerable Plaques, ROTTERDAM, Netherlands and DOYLESTOWN, ... Professor Patrick W. Serruys,successfully placed a vProtect(TM) Luminal Shield ... 64-year-old man at Erasmus Medical,Center in Rotterdam. This case ...
Cached Medicine Technology:Children's Brain Tumor Foundation's Tissue Bank Consortium May Solve Dire Problem in Pediatric Cancer Research 2Children's Brain Tumor Foundation's Tissue Bank Consortium May Solve Dire Problem in Pediatric Cancer Research 3Patient Receives vProtect(TM) Luminal Shield in First-Ever Vulnerable Plaque Clinical Trial 2Patient Receives vProtect(TM) Luminal Shield in First-Ever Vulnerable Plaque Clinical Trial 3
(Date:5/25/2015)... Iowa (PRWEB) May 25, 2015 ... Excellence awards for design of the wastewater ... City, Iowa.    The project received a National Recognition Award from ... Honor Award from ACEC – Iowa. Competitions held ... achievements. , The $50.2 million expansion is Iowa City’s ...
(Date:5/25/2015)... (PRWEB) May 25, 2015 ProDrop Light Show ... own VJ neon light backdrops with a click of a mouse. ... and much more all within Final Cut Pro X. , ProDrop ... such as drop zones, kaleidoscope and much more leaving infinite possibilities ... Show drop zones and text presets, users can apply their ...
(Date:5/25/2015)... (PRWEB) May 25, 2015 After the ... the radical science-based human wellness company Trivedi Master ... event from their world-class series titled, “Consciousness is Power.” ... on June 13, 2015 at the routinely allotted time ... The event will be made available to the public ...
(Date:5/25/2015)... White Plains, NY (PRWEB) May 25, 2015 ... LEED AP, principal of PBDW Architects in New York City, ... which is part of the hospital’s ongoing Legacy Lobby Lecture ... campus in White Plains. White is the great grandson of ... firm responsible for the design of Burke’s campus 100 years ...
(Date:5/24/2015)... Kong (PRWEB) May 25, 2015 Pacific Prime has ... three part report looking at the cost of individual international ... Destinations, Article 2 looks at the cost of health insurance in ... , Focusing on, Hong Kong , ... the UAE , the UK ...
Breaking Medicine News(10 mins):Health News:Stanley Consultants’ Expansion of Iowa City Wastewater Treatment Plant Wins National Award 2Health News:Stanley Consultants’ Expansion of Iowa City Wastewater Treatment Plant Wins National Award 3Health News:Developers at Pixel Film Studios Release of ProDrop Light Show for Final Cut Pro X. 2Health News:Hundreds of People Are Thrilled to Hear that Trivedi Master Wellness™ Promises to Hold Another Workshop in June 2015 2Health News:Hundreds of People Are Thrilled to Hear that Trivedi Master Wellness™ Promises to Hold Another Workshop in June 2015 3Health News:Burke Rehabilitation Hospital Welcomes Architect Samuel White, Descendant of McKim, Mead and White, for Legacy Lobby Lecture 2Health News:Burke Rehabilitation Hospital Welcomes Architect Samuel White, Descendant of McKim, Mead and White, for Legacy Lobby Lecture 3Health News:Pacific Prime Releases 2nd Article of Cost of Health Insurance Report 2
... study of sexual risk behaviors within long-term couples in ... much risk in their sexual behavior when they know ... as when they know their partner is already infected. ... antiretroviral therapy and in intensive counseling do engage in ...
... Boston University School of Medicine (BUSM) have discovered that ... have the propensity to become autoantigens. In a companion ... with dead cells and that the resulting DSautoantigen complexes ... in-vitro and in mouse models. These findings, which appear ...
... Slone Epidemiology Center, in collaboration with the Centers for ... Public Health, have reported widespread and increasing medication use ... in the American Journal of Obstetrics and Gynecology ... status, maternal age, race/ethnicity and state of residence. ...
... PA April 22, 2011 - Sanofi Pasteur, the ... NYSE: SNY), announced today that the U.S. Food and ... indication for its meningococcal conjugate vaccine, Menactra (Meningococcal [Groups ... Vaccine), to include a two-dose schedule for infants and ...
... (HealthDay News) -- While it may be true that beauty ... model helps reveal what,s behind peoples, ideas of facial attractiveness. ... "average" faces and those who fit the conventional notion of ... "femininity" in women. But psychologists Christopher P. Said of New ...
... American Society of Pediatric Otolaryngology (ASPO) will hold its ... 2011 Combined Otolaryngology Spring Meetings (COSM) - a joint ... During the ASPO meeting, hundreds of pieces of new ... will be presented focusing on children,s ear, nose, and ...
Cached Medicine News:Health News:Fighting HIV in South Africa should focus on couples, study finds 2Health News:Fighting HIV in South Africa should focus on couples, study finds 3Health News:Researchers identify novel pathophysiologic mechanism responsible for autoimmunity 2Health News:Researchers report widespread use of medications among pregnant women 2Health News:Sanofi Pasteur announces FDA approval of menactra meningococcal conjugate vaccine indication for infants 2Health News:What Makes a Face Appealing to the Opposite Sex? 2Health News:Scientific session and new research highlights from the American Society of Pediatric Otolaryngology Meeting 2
... Flowstar is a compact and digital ... The investigation starts automatically when the ... volume scales can be adjusted and ... user selectable. Siroky flow plots can ...
UroPass Open Tip Ureteral Stents perfect over-the-wire placement with a combination of flexibility and rigidity for comfort and control. When it comes to stent designs, UroPass is a proven leader....
... ACMI™ Uro-Guide Open ... the first silicone over-the-wire ... classic Double-J design with ... are composed of time-tested ...
... Open Tip Ureteral Stents combine a unique ... while remembering its shape with a chemically ... moistened. The result is a stent that ... and patient comfort. Lubri-Flex® is available in ...
Medicine Products: